Ph. I Dasatinib/Protracted Temozolomide in Recurrent Malignant Glioma

This study has been withdrawn prior to enrollment.

( Study drug supplier withdrew support for the study. Study was withdrawn from the Duke IRB. )

Study NCT00734864 Information provided by Duke University

First Received: May 4, 2008 Last Updated: January 22, 2009 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study was withdrawn before participants were enrolled.

Study Status:	This study has been withdrawn prior to enrollment.
Estimated Study Completion Date:	June 2012
Estimated Primary Completion Date:	June 2010 (Final data collection date for primary outcome measure)